InvestorsHub Logo
Followers 12
Posts 367
Boards Moderated 0
Alias Born 04/02/2014

Re: flipper44 post# 449484

Tuesday, 03/08/2022 5:04:11 PM

Tuesday, March 08, 2022 5:04:11 PM

Post# of 703283
How Come Sawton can make DC Vax up to 50 patients per month and the US compassionate use program/right to try program is useless. We need to write our Congressional Representatives and Senators.

How Come we all we do is post on IHUB and are not contacting Joe Biden - whose son Beau died of Brain Cancer. He has a Moon Shot program to Cure cancer does not have NWBO front and center as a company who can likely cure 20 to 30% of GBM cases but is not challenging the FDA to approve DC Vax that is part of a trial that is still waiting for results after more than 12 years.

How Come we are not contacting all major news outlets and telling them about DC Vax? Remember around 2016 a company called Sarepta Therapeutics had parents pushing the FDA to approve their Duchenne Muscular Dystrophy drug. Their efforts help push this drug over the finish line. How Come we can’t do something similar.

I don’t post often but what are we accomplishing by posting to a message board when we can more effectively spend that time in a productive way by being pro-active Today, I decided to be like the parents of MD children and become an advocate for NWBO. Here is my first step.

I tweeted Dr Marc Siegel of Fox news asking How Come DCVAX is available to the UK on a compassionate use basis and the US is leading from behind. Maybe he will think it worth coverage at Fox news and do a follow-up story.

I plan to write President Biden and ask him How Come we have a Moon Shot program and Right to Try but there is no approval for DCVAX after more than 12 years. My Congress women and two senators are next.

We have many intelligent people on this board that should have their own How Come questions. Why not spend more time asking How Come and influencing the masses and less time posting to the IHUB message board.

Maybe we can make a difference the same way parents influenced the FDA to approve Sarepta Therapeutics drug for MD.

If you think this is a bad idea, I have to ask you - How Come? Let's take a new approach because we have a right to try!


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News